AbbVie secures Canadian support for Skyrizi in ulcerative colitis with new reimbursement recommendations and a completed pCPA agreement.

SKYRIZI® (risankizumab), an IL-23 inhibitor, received two consecutive positive reimbursement recommendations by Canada’s Drug ...

SKYRIZI® (risankizumab), an IL-23 inhibitor, received two consecutive positive reimbursement recommendations by Canada’s Drug ...

Gut bacteria shown to produce serotonin, revealing new pathways for IBS therapy. Researchers at the University of Gothenburg in Sweden have uncovered new details about how gut bacteria interact with ...

Chris Kirt was just 31 when he was diagnosed with colon cancer after experiencing five symptoms including night sweats and unexpected tiredness, and he's now urging people to take any signs seriously ...

A new study found that a popular low-calorie sweetener commonly used in sugar-free gum, candies and diet-friendly baked goods ...

Walk into a typical supermarket in the United States, and much of what you see — breakfast cereals, frozen meals, processed ...

IT affects one in eight men, and so it seems logical to have a prostate cancer screening programme. And yet, in a pivotal ...

Thanksgiving is over, but the holiday hazards for pets are just getting started. Every year, veterinary clinics see a spike ...

When British expatriate Melanie discovered that she developed an intolerance to gluten; she remembers feeling “overwhelmed, ...

Prostate cancer decision by UK National Screening Committee is expected to reject offering PSA test to Black men and those ...

There is currently no screening programme for prostate cancer, the most common cancer in men. But there has been some ...